{"organizations": [], "uuid": "496fa04cb2b64935451abaffcf3da5e6dd783911", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-oncolytics-biotech-receives-shareh/brief-oncolytics-biotech-receives-shareholder-approval-to-consolidate-companys-common-shares-at-its-february-23-2018-special-meeting-of-shareholders-idUSFWN1QD1HK", "country": "US", "domain_rank": 408, "title": "BRIEF-Oncolytics Biotech Receives Shareholder Approval To Consolidate Company's Common Shares At Its February 23, 2018 Special Meeting Of Shareholders", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-24T00:39:00.000+02:00", "replies_count": 0, "uuid": "496fa04cb2b64935451abaffcf3da5e6dd783911"}, "author": "", "url": "https://www.reuters.com/article/brief-oncolytics-biotech-receives-shareh/brief-oncolytics-biotech-receives-shareholder-approval-to-consolidate-companys-common-shares-at-its-february-23-2018-special-meeting-of-shareholders-idUSFWN1QD1HK", "ord_in_thread": 0, "title": "BRIEF-Oncolytics Biotech Receives Shareholder Approval To Consolidate Company's Common Shares At Its February 23, 2018 Special Meeting Of Shareholders", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-oncolytics biotech receives shareholder approval to consolidate company", "sentiment": "neutral"}, {"name": "consolidate company", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "oncolytics biotech inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 23 (Reuters) - Oncolytics Biotech Inc:\n* ONCOLYTICS BIOTECH INC - RECEIVED SHAREHOLDER APPROVAL TO CONSOLIDATE COMPANYâ€˜S COMMON SHARES AT ITS FEBRUARY 23, 2018 SPECIAL MEETING OF SHAREHOLDERS Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-24T00:39:00.000+02:00", "crawled": "2018-02-24T00:54:48.022+02:00", "highlightTitle": ""}